The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Aspirin plus Heparin or Aspirin Alone in Women with Recurrent Miscarriage
Abstract
BACKGROUND: Aspirin and low-molecular-weight heparin are prescribed for women with unexplained recurrent miscarriage, with the goal of improving the rate of live births, but limited data from randomized, controlled trials are available to support the use of these drugs. METHODS: In this randomized trial, we enrolled 364 women between the ages of 18 and 42 years who had a history of unexplained recurrent miscarriage and were attempting to conceive or were less than 6 weeks pregnant. We then randomly assigned them to receive daily 80 mg of aspirin plus open-label subcutaneous nadroparin (at a dose of 2850 IU, starting as soon as a viable pregnancy was demonstrated), 80 mg of aspirin alone, or placebo. The primary outcome measure was the live-birth rate. Secondary outcomes included rates of miscarriage, obstetrical complications, and maternal and fetal adverse events. RESULTS: Live-birth rates did not differ significantly among the three study groups. The proportions of women who gave birth to a live infant were 54.5% in the group receiving aspirin plus nadroparin (combination-therapy group), 50.8% in the aspirin-only group, and 57.0% in the placebo group (absolute difference in live-birth rate: combination therapy vs. placebo, -2.6 percentage points; 95% confidence interval [CI], -15.0 to 9.9; aspirin only vs. placebo, -6.2 percentage points; 95% CI, -18.8 to 6.4). Among 299 women who became pregnant, the live-birth rates were 69.1% in the combination-therapy group, 61.6% in the aspirin-only group, and 67.0% in the placebo group (absolute difference in live-birth rate: combination therapy vs. placebo, 2.1 percentage points; 95% CI, -10.8 to 15.0; aspirin alone vs. placebo -5.4 percentage points; 95% CI, -18.6 to 7.8). An increased tendency to bruise and swelling or itching at the injection site occurred significantly more frequently in the combination-therapy group than in the other two study groups. CONCLUSIONS: Neither aspirin combined with nadroparin nor aspirin alone improved the live-birth rate, as compared with placebo, among women with unexplained recurrent miscarriage. (Current Controlled Trials number, ISRCTN58496168.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Badawy, A., Khiary, M., Sherif, L., Hassan, M. E., Ragab, A., & Abdelall, I. (2008) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610802042688 · Cited by 122
RetractedInteraction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Maternal age and fetal loss: population based register linkage study
Andersen, A.-M. N. (2000) · BMJ · doi:10.1136/bmj.320.7251.1708 · Cited by 1,690
Rai, R., & Regan, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69204-0 · Cited by 1,227
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage
Jauniaux, E. (2006) · Human Reproduction · doi:10.1093/humrep/del150 · Cited by 520
Epidemiology and the medical causes of miscarriage
Regan, L., & Rai, R. (2000) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2000.0123 · Cited by 512
Gnoth, C. (2003) · Human Reproduction · doi:10.1093/humrep/deg366 · Cited by 458
Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment
Farquharson, R. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02165-8 · Cited by 427
Influence of past reproductive performance on risk of spontaneous abortion.
Regan, L., Braude, P. R., & Trembath, P. L. (1989) · BMJ · doi:10.1136/bmj.299.6698.541 · Cited by 420
A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage
Brigham, S. A., Conlon, C., & Farquharson, R. G. (1999) · Human Reproduction · doi:10.1093/humrep/14.11.2868 · Cited by 365
Evidence-based investigations and treatments of recurrent pregnancy loss
Christiansen, O. B., Nybo Andersen, A.-M., Bosch, E., Daya, S., Delves, P. J., Hviid, T. V., Kutteh, W. H., Laird, S. M., Li, T.-C., & van der Ven, K. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.12.018 · Cited by 302
The thrombomodulin–protein C system is essential for the maintenance of pregnancy
Isermann, B., Sood, R., Pawlinski, R., Zogg, M., Kalloway, S., Degen, J. L., Mackman, N., & Weiler, H. (2003) · Nature Medicine · doi:10.1038/nm825 · Cited by 263
Lupus Anticoagulants, Anticardiolipin Antibodies, and Fetal Loss: A Case–Control Study
Infante-Rivard, C., David, M., Gauthier, R., & Rivard, G.-E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110103251503 · Cited by 205
ACOG PRACTICE BULLETIN: NO 24, FEB 2001, MANAGEMENT OF RECURRENT EARLY PREGNANCY LOSS
(2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(02)00197-2 · Cited by 174
Tulppala, M., Marttunen, M., Soderstrom-Anttila, V., Foudila, T., Ailus, K., Palosuo, T., & Ylikorkala, O. (1997) · Human Reproduction · doi:10.1093/humrep/12.7.1567 · Cited by 172
Heparin and aspirin attenuate placental apoptosis in vitro: Implications for early pregnancy failure
Bose, P., Black, S., Kadyrov, M., Weissenborn, U., Neulen, J., Regan, L., & Huppertz, B. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.09.029 · Cited by 166
Prognosis of a new pregnancy following previous spontaneous abortions
Knudsen, U. B., Hansen, V., Juul, S., & Secher, N. J. (1991) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(91)90138-b · Cited by 158
Inherited Thrombophilia and Pregnancy Complications Revisited
Rodger, M. A., Paidas, M. J., McLintock, C., Middeldorp, S., Kahn, S. R., Martinelli, I., Hague, W. M., Montella, K. R., & Greer, I. A. (2008) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31817e8acc · Cited by 142
Self-citationDolitzki, M., Inbal, A., Segal, Y., Weiss, A., Brenner, B., & Carp, H. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.12.068 · Cited by 136
Fawzy, M., Shokeir, T. A., El-Tatongy, M., Warda, O. M., El-Refaiey, A.-A. A., & Mosbah, A. (2007) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-007-0527-x · Cited by 135
Circulating Procoagulant Microparticles in Women with Unexplained Pregnancy Loss: a New Insight
Laude, I., Rongières-Bertrand, C., Boyer‐Neumann, C., Wolf, M., Mairovitz, V., Hugel, B., Freyssinet, J., Frydman, R., Eschwège, V., & Meyer, D. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612657 · Cited by 129
Parental karyotype and subsequent live births in recurrent miscarriage
Carp, H., Feldman, B., Oelsner, G., & Schiff, E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.09.059 · Cited by 125
Thrombophilia and pregnancy complications: cause or association?
Middeldorp, S. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02501.x · Cited by 113
Self-citationFactor V Leiden and recurrent miscarriage--prospective outcome of untreated pregnancies
Rai, R., Backos, M., Elgaddal, S., Shlebak, A., & Regan, L. (2002) · Human Reproduction · doi:10.1093/humrep/17.2.442 · Cited by 106
Genetic aspects of female reproduction
The ESHRE Capri Workshop Group (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn009 · Cited by 87
Recurrent miscarriage and long-term thrombosis risk: a case–control study
Quenby, S. M., Farquharson, R. G., Dawood, F. A., Hughes, A. M., & Topping, J. (2005) · Human Reproduction · doi:10.1093/humrep/deh844 · Cited by 87
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – Yes
Brenner, B. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00504.x · Cited by 58
Freundl, G., Godehardt, E., Kern, P. A., Frank-Herrmann, P., Koubenec, H. J., & Gnoth, C. (2003) · Human Reproduction · doi:10.1093/humrep/deg488 · Cited by 58
Pregnancy Loss in the Antiphospholipid Syndrome
Lockshin, M. D. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615891 · Cited by 52
Middeldorp, S., & Levi, M. M. (2007) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-985752 · Cited by 48
Self-citation
Cited by
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Self-citationCyclic Decidualization of the Human Endometrium in Reproductive Health and Failure
Gellersen, B., & Brosens, J. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1045 · Cited by 1,139
Dimitriadis, E., Menkhorst, E., Saito, S., Kutteh, W. H., & Brosens, J. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00228-z · Cited by 702
Recurrent pregnancy loss: current perspectives
El Hachem, H., Crepaux, V., May-Panloup, P., Descamps, P., Legendre, G., & Bouet, P.-E. (2017) · International Journal of Women's Health · doi:10.2147/ijwh.s100817 · Cited by 462
Branch, D. W., Gibson, M., & Silver, R. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1005330 · Cited by 326
Metadata
- Authors
- Kaandorp, S. P., Goddijn, M., van der Post, J. A. M., Hutten, B. A., Verhoeve, H. R., Hamulyák, K., Mol, B. W., Folkeringa, N., Nahuis, M., Papatsonis, D. N. M., Büller, H. R., van der Veen, F., & Middeldorp, S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-04-29
- Volume
- 362
- Issue
- 17
- Pages
- 1586-1596
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2104283275
- Cited by
- 450
- References
- 31
- FWCI
- 16.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.